101
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Incidence, Predictors and Clinical Impact of Ventricular Electrical Storm in Arrhythmogenic Cardiomyopathy Patients with an Implantable Cardioverter–Defibrillator: A Single-Center Report with Medium-Term Follow-Up

, , , , , & show all
Pages 10055-10063 | Published online: 20 Dec 2021

References

  • Corrado D, Link MS, Calkins H, Jarcho JA. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):1489–1490. doi:10.1056/NEJMra1509267
  • Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 hrs expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301–e372. doi:10.1016/j.hrthm.2019.05.007
  • Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 aha/acc/hrs guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e210–e271. doi:10.1161/CIR.0000000000000548
  • Kowlgi GN, Cha Y-M. Management of ventricular electrical storm: a contemporary appraisal. Europace. 2020;22(12):1768–1780. doi:10.1093/europace/euaa232
  • Noda T, Kurita T, Nitta T, et al. Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator. Int J Cardiol. 2018;255:85–91. doi:10.1016/j.ijcard.2017.11.077
  • Zhang N, Song Y, Hua W, et al. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs. Int J Cardiol. 2021;337:79–85. doi:10.1016/j.ijcard.2021.04.015
  • Yin K, Ding L, Li Y, et al. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death. Clin Cardiol. 2017;40(4):216–221. doi:10.1002/clc.22648
  • Mussigbrodt A, Dinov B, Bertagnoli L, et al. Precordial QRS amplitude ratio predicts long-term outcome after catheter ablation of electrical storm due to ventricular tachycardias in patients with arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol. 2015;48:86–92. doi:10.1016/j.jelectrocard.2014.10.013
  • Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533–1541. doi:10.1161/CIRCULATIONAHA.108.840827
  • Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol. 2007;12:375–382. doi:10.1111/j.1542-474X.2007.00187.x
  • Peters S, Trummel M. Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. Ann Noninvasive Electrocardiol. 2003;8:238–245. doi:10.1046/j.1542-474X.2003.08312.x
  • Bansch D, Bocker D, Brunn J, et al. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol. 2000;36(2):566–573. doi:10.1016/S0735-1097(00)00726-9
  • Roguin A, Bomma CS, Nasir K, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004;43(10):1843–1852. doi:10.1016/j.jacc.2004.01.030
  • Yin K, Ding L, Hua W, et al. Electrical storm in icd recipients with arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol. 2017;40(6):683–692. doi:10.1111/pace.13070
  • Santangeli P, Muser D, Maeda S, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13(7):1552–1559. doi:10.1016/j.hrthm.2016.03.004
  • Guerra F, Shkoza M, Scappini L, et al. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. Europace. 2014;16(3):347–353. doi:10.1093/europace/eut304
  • Samanta R, Narayan A, Pouliopoulos J, et al. Influence of body mass index on recurrence of ventricular arrhythmia, mortality in defibrillator recipients with ischaemic cardiomyopathy. Heart Lung Circ. 2020;29(2):254–261. doi:10.1016/j.hlc.2018.12.018
  • Pietrasik G, Goldenberg I, McNitt S, et al. Obesity as a risk factor for sustained ventricular tachyarrhythmias in madit ii patients. J Cardiovasc Electrophysiol. 2007;18(2):181–184. doi:10.1111/j.1540-8167.2006.00680.x
  • Zagkli F, Georgakopoulou A, Chiladakis J. QRS fragmentation and T-wave inversion as factors of vulnerability to recurrent ventricular tachycardia. Future Cardiol. 2019;15:89–93. doi:10.2217/fca-2017-0104
  • Jain R, Dalal D, Daly A, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation. 2009;120(6):477–487. doi:10.1161/CIRCULATIONAHA.108.838821
  • Kato J, Koike A, Kuroki K, et al. Safety and efficacy of in-hospital cardiac rehabilitation following antiarrhythmic therapy for patients with electrical storm. J Cardiol. 2019;73(2):171–178. doi:10.1016/j.jjcc.2018.08.004
  • Brigadeau F, Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J. 2006;27(6):700–707. doi:10.1093/eurheartj/ehi726
  • Guerra F, Flori M, Bonelli P, et al. Electrical storm and heart failure worsening in implantable cardiac defibrillator patients. Europace. 2015;17(2):247–254. doi:10.1093/europace/euu298
  • Liang E, Wu L, Fan S, et al. Catheter ablation of arrhythmogenic right ventricular cardiomyopathy ventricular tachycardia: 18-year experience in 284 patients. Europace. 2020;22(5):806–812. doi:10.1093/europace/euaa046